CA2153151A1
(en)
*
|
1993-02-17 |
1994-09-01 |
Robert Charles Hider |
Polymeric compounds
|
US5487888A
(en)
*
|
1993-05-20 |
1996-01-30 |
Geltex, Inc. |
Iron-binding polymers for oral administration
|
US5667775A
(en)
|
1993-08-11 |
1997-09-16 |
Geltex Pharmaceuticals, Inc. |
Phosphate-binding polymers for oral administration
|
GB9503061D0
(en)
*
|
1995-02-16 |
1995-04-05 |
British Tech Group |
Polymeric compounds
|
DE19528524C2
(de)
*
|
1995-08-03 |
1999-11-11 |
Hans Dietl |
Calciumhaltiges Mittel zur intestinalen Phosphatbindung und Verfahren zu seiner Herstellung
|
DE69705877T2
(de)
*
|
1996-03-05 |
2002-06-06 |
Mitsubishi Chemical Corp., Tokio/Tokyo |
Verwendung von Anionenaustauscherharzen zur Herstellung eines Arzneimittels zur Behandlung der Hyperphosphatemie
|
US6180094B1
(en)
|
1996-07-19 |
2001-01-30 |
Nikken Chemicals Co., Ltd. |
Remedies for hyperphosphatemia
|
JP4358303B2
(ja)
*
|
1996-10-23 |
2009-11-04 |
ダウ グローバル テクノロジーズ インコーポレイティド |
食物ホスフェート又はオキサレート吸収を低下させるための水溶性ポリマー
|
AU2446497A
(en)
*
|
1997-03-25 |
1998-10-20 |
Geltex Pharmaceuticals, Inc. |
Phosphate-binding polymers combined with a calcium supplement for oral administration
|
TW592727B
(en)
*
|
1997-04-04 |
2004-06-21 |
Chugai Pharmaceutical Co Ltd |
Phosphate-binding polymer preparations
|
US6423754B1
(en)
*
|
1997-06-18 |
2002-07-23 |
Geltex Pharmaceuticals, Inc. |
Method for treating hypercholesterolemia with polyallylamine polymers
|
NZ516848A
(en)
*
|
1997-06-20 |
2004-03-26 |
Ciphergen Biosystems Inc |
Retentate chromatography apparatus with applications in biology and medicine
|
US5985938A
(en)
*
|
1997-11-05 |
1999-11-16 |
Geltex Pharmaceuticals, Inc. |
Method for reducing oxalate
|
US6566407B2
(en)
|
1997-11-05 |
2003-05-20 |
Geltex Pharmaceuticals, Inc. |
Method for reducing oxalate
|
US6726905B1
(en)
|
1997-11-05 |
2004-04-27 |
Genzyme Corporation |
Poly (diallylamines)-based phosphate binders
|
WO1999040990A1
(en)
*
|
1998-02-17 |
1999-08-19 |
University Of Maryland |
Anion binding polymers and the use thereof
|
AU3005599A
(en)
*
|
1998-03-19 |
1999-10-11 |
Geltex Pharmaceuticals, Inc. |
Continuous crosslinking of polymer gels
|
US6294163B1
(en)
|
1998-10-02 |
2001-09-25 |
Geltex Pharmaceuticals, Inc. |
Polymers containing guanidinium groups as bile acid sequestrants
|
JP4749649B2
(ja)
*
|
1998-10-12 |
2011-08-17 |
中外製薬株式会社 |
リン酸結合性ポリマー
|
TW568788B
(en)
|
1998-10-12 |
2004-01-01 |
Chugai Pharmaceutical Co Ltd |
Polymer combining with phosphoric acid and preparation containing the same
|
US6271264B1
(en)
|
1998-12-01 |
2001-08-07 |
Geltex Pharmaceuticals, Inc. |
Polymers containing spirobicyclic ammonium moieties as bile acid sequestrants
|
EP1175451B1
(en)
*
|
1999-04-16 |
2007-07-04 |
Abbott Laboratories |
Process for producing cross-linked polyallylamine hydrochloride
|
US6190649B1
(en)
|
1999-04-23 |
2001-02-20 |
Geltex Pharmaceuticals, Inc. |
Polyether-based bile acid sequestrants
|
US6180754B1
(en)
|
1999-09-03 |
2001-01-30 |
The Dow Chemical Company |
Process for producing cross-linked polyallylamine polymer
|
US6362266B1
(en)
|
1999-09-03 |
2002-03-26 |
The Dow Chemical Company |
Process for reducing cohesiveness of polyallylamine polymer gels during drying
|
AU7856200A
(en)
*
|
1999-10-07 |
2001-05-10 |
University Of Maryland |
Sugar binding polymers and the use thereof
|
US20030202958A1
(en)
*
|
1999-10-15 |
2003-10-30 |
Strickland Alan D. |
Dialysis solution including polyglycol osmotic agent
|
WO2001028544A2
(en)
*
|
1999-10-15 |
2001-04-26 |
The Dow Chemical Company |
Dialysis solution including polyglycol osmotic agent
|
US6733780B1
(en)
*
|
1999-10-19 |
2004-05-11 |
Genzyme Corporation |
Direct compression polymer tablet core
|
US20020054903A1
(en)
*
|
1999-10-19 |
2002-05-09 |
Joseph Tyler |
Direct compression polymer tablet core
|
IL149146A0
(en)
*
|
1999-10-19 |
2002-11-10 |
Geltex Pharma Inc |
Direct compression polymer tablet core
|
US20040059065A1
(en)
*
|
2000-03-09 |
2004-03-25 |
Takeshi Goto |
Crosslinked anion-exchange resin or salt thereof
|
US6844372B2
(en)
|
2000-03-09 |
2005-01-18 |
Hisamitsu Pharmaceutical Co., Inc. |
Crosslinked anion-exchange resin or salt thereof and phosphorus adsorbent comprising the same
|
WO2001068106A1
(fr)
|
2000-03-13 |
2001-09-20 |
Hisamitsu Pharmaceutical Co., Inc. |
Prophylactiques et/ou remedes pour hyperphosphatemie
|
WO2002032974A2
(en)
*
|
2000-10-18 |
2002-04-25 |
Fujisawa Pharmaceutical Co., Ltd. |
Polymer and its use for the treatment and/or prevention of hyperphosphoremia
|
DE60142527D1
(de)
*
|
2000-11-28 |
2010-08-19 |
Mitsubishi Tanabe Pharma Corp |
Exkretionsbeschleuniger für eine akkumulative chlorverbindung
|
KR100771322B1
(ko)
*
|
2000-11-28 |
2007-10-29 |
미쯔비시 웰 파마 가부시키가이샤 |
항비만제 및 건강식품
|
AT409630B
(de)
*
|
2000-12-13 |
2002-09-25 |
Dsm Fine Chem Austria Gmbh |
Alkylierung von n-bzw. amino- oder ammoniumgruppen haltigen, vernetzten polymeren
|
DE10065710A1
(de)
*
|
2000-12-29 |
2002-07-04 |
Bayer Ag |
Arzneimittel enthaltend ein Polyamin als Wirksubstanz
|
WO2002066543A1
(en)
*
|
2001-02-16 |
2002-08-29 |
Genzyme Corporation |
Method of drying a material having a cohesive phase
|
WO2002085379A1
(en)
*
|
2001-04-18 |
2002-10-31 |
Geltex Pharmaceuticals, Inc. |
Method for improving vascular access in patients with vascular shunts
|
EP1923064B1
(en)
|
2001-04-18 |
2017-06-28 |
Genzyme Corporation |
Use of amine polymer for lowering serum glucose
|
AU2002257147B9
(en)
*
|
2001-04-18 |
2005-08-18 |
Genzyme Corporation |
Methods of treating syndrome X with aliphatic polyamines
|
AU2002257145B2
(en)
*
|
2001-04-18 |
2005-06-02 |
Genzyme Corporation |
Method for lowering serum glucose
|
NZ528829A
(en)
*
|
2001-04-18 |
2006-06-30 |
Genzyme Corp |
Low salt forms of polyallylamine
|
MX2008011686A
(es)
*
|
2001-05-25 |
2010-05-27 |
Marathon Oil Co |
Inhibicion de sulfuracion del deposito utilizando una inyeccion de agua tratada.
|
US7041280B2
(en)
*
|
2001-06-29 |
2006-05-09 |
Genzyme Corporation |
Aryl boronate functionalized polymers for treating obesity
|
JP2003033651A
(ja)
*
|
2001-07-24 |
2003-02-04 |
Chisso Corp |
経口リン吸着剤及びそれを含む食品
|
CA2454732C
(en)
|
2001-07-30 |
2010-07-20 |
Mitsubishi Pharma Corporation |
Drugs for ameliorating postcibal hyperglycemia
|
US6600011B2
(en)
|
2001-10-09 |
2003-07-29 |
Genzyme Corporation |
Process for purification and drying of polymer hydrogels
|
FR2833169B1
(fr)
*
|
2001-12-07 |
2004-07-16 |
Oreal |
Composition filtrante contenant un derive de 1,3,5-triazine, un derive du dibenzoylmethane, et un derive de 2-hydroxybenzophenone aminosubstitue
|
US7119120B2
(en)
*
|
2001-12-26 |
2006-10-10 |
Genzyme Corporation |
Phosphate transport inhibitors
|
IL163666A0
(en)
|
2002-02-22 |
2005-12-18 |
New River Pharmaceuticals Inc |
Active agent delivery systems and methods for protecting and administering active agents
|
AU2003218270A1
(en)
*
|
2002-03-19 |
2003-10-08 |
Genzyme Corporation |
Phosphate transport inhibitors
|
AT411463B
(de)
|
2002-09-03 |
2004-01-26 |
Dsm Fine Chem Austria Gmbh |
Verfahren zur herstellung von alkylierten n- bzw. amino-, ammonium- oder spirobicyclischen ammoniumgruppen haltigen, vernetzten polymeren
|
WO2004037274A1
(en)
*
|
2002-10-22 |
2004-05-06 |
Genzyme Corporation |
Amine polymers for promoting bone formation
|
AT412473B
(de)
|
2003-01-15 |
2005-03-25 |
Dsm Fine Chem Austria Gmbh |
Verfahren zur kontinuierlichen trocknung von n- bzw. amino-, ammonium- oder spirobicyclische ammoniumgruppen haltigen polymeren
|
US7335795B2
(en)
|
2004-03-22 |
2008-02-26 |
Ilypsa, Inc. |
Crosslinked amine polymers
|
US7459502B2
(en)
*
|
2003-11-03 |
2008-12-02 |
Ilypsa, Inc. |
Pharmaceutical compositions comprising crosslinked polyamine polymers
|
US7608674B2
(en)
*
|
2003-11-03 |
2009-10-27 |
Ilypsa, Inc. |
Pharmaceutical compositions comprising cross-linked small molecule amine polymers
|
US7767768B2
(en)
*
|
2003-11-03 |
2010-08-03 |
Ilypsa, Inc. |
Crosslinked amine polymers
|
US7385012B2
(en)
*
|
2003-11-03 |
2008-06-10 |
Ilypsa, Inc. |
Polyamine polymers
|
US7449605B2
(en)
*
|
2003-11-03 |
2008-11-11 |
Ilypsa, Inc. |
Crosslinked amine polymers
|
US8519058B2
(en)
*
|
2004-02-23 |
2013-08-27 |
E I Du Pont De Nemours And Company |
Crosslinked polymers containing biomass derived materials
|
US8426528B2
(en)
*
|
2004-02-23 |
2013-04-23 |
E I Du Pont De Nemours And Company |
Preparation of crosslinked polymers containing biomass derived materials
|
CA2560927C
(en)
|
2004-03-26 |
2013-05-14 |
Mitsubishi Pharma Corporation |
Insulin resistance-improving agent
|
ES2453048T3
(es)
|
2004-03-30 |
2014-04-03 |
Relypsa, Inc. |
Polímeros de unión de ión y usos de los mismos
|
US20050276781A1
(en)
*
|
2004-06-09 |
2005-12-15 |
Ross Edward A |
Molecularly imprinted phosphate binders for therapeutic use
|
JP5079510B2
(ja)
*
|
2004-09-24 |
2012-11-21 |
バイオスフィア メディカル, インコーポレイテッド |
放射性同位体を結合し得、任意選択的に金属微粒子を含むミクロスフェア、およびそれらの使用方法
|
CA2583634C
(en)
*
|
2004-10-13 |
2013-03-19 |
Ilypsa, Inc. |
Crosslinked amine polymers
|
US7985418B2
(en)
*
|
2004-11-01 |
2011-07-26 |
Genzyme Corporation |
Aliphatic amine polymer salts for tableting
|
US20060177415A1
(en)
*
|
2004-11-01 |
2006-08-10 |
Burke Steven K |
Once a day formulation for phosphate binders
|
JP4547620B2
(ja)
*
|
2004-12-02 |
2010-09-22 |
日東紡績株式会社 |
架橋アリルアミン類重合体の製造方法
|
ITME20040015A1
(it)
*
|
2004-12-07 |
2005-03-07 |
Vincenzo Savica |
Chewing gum, caramelle gommose, pastiglie, compresse a lento rilascio di chelanti fosfato e/o fosforo salivare e capsule a lento rilascio di chelanti fosfato e/o fosforo a livello gastroenterico.
|
JP2008526771A
(ja)
*
|
2004-12-30 |
2008-07-24 |
ジェンザイム コーポレーション |
高リン酸血症のための亜鉛含有処置
|
WO2006091901A1
(en)
*
|
2005-02-23 |
2006-08-31 |
E.I. Dupont De Nemours And Company |
Processes using alpha, omega-difunctional aldaramides as monomers and crosslinkers
|
JP2008533272A
(ja)
*
|
2005-03-16 |
2008-08-21 |
ユーエスヴィー リミテッド |
架橋ポリアリルアミンポリマーの調製のための改良された方法
|
JP4903796B2
(ja)
|
2005-08-17 |
2012-03-28 |
ヒルズ・ペット・ニュートリシャン・インコーポレーテッド |
腎疾患の予防及び治療のための方法及び組成物
|
US8986669B2
(en)
*
|
2005-09-02 |
2015-03-24 |
Genzyme Corporation |
Method for removing phosphate and polymer used therefore
|
AR056499A1
(es)
*
|
2005-09-06 |
2007-10-10 |
Serapis Farmaceuticals Ltd |
Compuestos
|
CN103027896B
(zh)
*
|
2005-09-15 |
2016-01-20 |
基酶有限公司 |
胺聚合物的小袋制剂
|
AU2012205214B2
(en)
*
|
2005-09-15 |
2015-05-21 |
Genzyme Corporation |
Formulation for Amine Polymers
|
KR20080057319A
(ko)
|
2005-09-30 |
2008-06-24 |
일립사, 인코포레이티드 |
가교 쉘을 갖는 코어-쉘 복합체의 제조 방법, 및 이로부터수득되는 코어-쉘 복합체
|
WO2007041569A1
(en)
|
2005-09-30 |
2007-04-12 |
Ilypsa, Inc. |
Methods and compositions for selectively removing potassium ion from the gastrointestinal tract of a mammal
|
BRPI0618352A2
(pt)
*
|
2005-11-08 |
2011-08-23 |
Genzyme Corp |
composições farmacêuticas e métodos de tratamento da hiperfosfatemia em um paciente
|
WO2007070801A2
(en)
*
|
2005-12-12 |
2007-06-21 |
Allaccem, Inc. |
Methods and systems for preparing antimicrobial films and coatings
|
ITRM20060204A1
(it)
*
|
2006-04-10 |
2007-10-11 |
Vincenzo Savica |
Farmaci e alimentei per diete normoproteiche iperproteiche ipopro teiche tutte ipofosforiche e bevande ipofosforiche
|
EP2016114A2
(en)
*
|
2006-05-05 |
2009-01-21 |
Genzyme Corporation |
Amine condensation polymers as phosphate sequestrants
|
JP5147695B2
(ja)
|
2006-06-16 |
2013-02-20 |
田辺三菱製薬株式会社 |
糸球体疾患の予防及び/または治療剤
|
US20100135950A1
(en)
*
|
2006-07-05 |
2010-06-03 |
Genzyme Corporation |
Iron(II)-Containing Treatments for Hyperphosphatemia
|
BRPI0715053A2
(pt)
*
|
2006-07-18 |
2013-03-19 |
Genzyme Corp |
composiÇço farmacÊutica, mÉtodo para tratar doenÇas, e, polÍmero
|
WO2008018556A1
(en)
|
2006-08-09 |
2008-02-14 |
Mitsubishi Tanabe Pharma Corporation |
Tablet
|
US7964182B2
(en)
*
|
2006-09-01 |
2011-06-21 |
USV, Ltd |
Pharmaceutical compositions comprising phosphate-binding polymer
|
BRPI0717008A2
(pt)
*
|
2006-09-01 |
2014-01-21 |
Usv Ltd |
Processo para o preparo de cloridrato de sevelamer e formulação do mesmo
|
WO2008042222A2
(en)
|
2006-09-29 |
2008-04-10 |
Genzyme Corporation |
Amide dendrimer compositions
|
BRPI0716319A8
(pt)
|
2006-10-25 |
2019-02-05 |
Aovatechnologies Inc |
método para reduzir a absorção de fosfato em um indivíduo animal humano ou não-humano correndo o risco de desenvolver ou que desenvolveu hiperfosfatomia e método para reduzir os efeitos colaterais da terapia de vitamina d em um ser humano
|
JP5701504B2
(ja)
|
2006-10-26 |
2015-04-15 |
ウィスコンシン アルムニ リサーチ ファンデイション |
リン酸塩吸収の低減方法
|
US8163799B2
(en)
*
|
2006-12-14 |
2012-04-24 |
Genzyme Corporation |
Amido-amine polymer compositions
|
JP2008169758A
(ja)
*
|
2007-01-11 |
2008-07-24 |
Bosch Corp |
ターボチャージャ駆動制御方法及びその装置
|
EP2125026B1
(en)
|
2007-02-21 |
2014-09-24 |
AllAccem, Inc. |
Bridged polycyclic compound based compositions for the inhibition and amelioration of disease
|
JP2010519298A
(ja)
*
|
2007-02-23 |
2010-06-03 |
ゲンズイメ コーポレーション |
アミンポリマー組成物
|
EP2131820A1
(en)
*
|
2007-03-08 |
2009-12-16 |
Genzyme Corporation |
Sulfone polymer compositions
|
US8034833B2
(en)
*
|
2008-03-20 |
2011-10-11 |
Biolink Life Sciences, Inc. |
Phosphorus binder for treatment of renal disease
|
EP2152277A1
(en)
*
|
2007-04-27 |
2010-02-17 |
Genzyme Corporation |
Amido-amine dendrimer compositions
|
RU2010104673A
(ru)
|
2007-07-11 |
2011-08-20 |
Торэй Индастриз, Инк. (Jp) |
Сшитый полиаллиламин или его соль присоединения кислоты и его применение для медицинских целей
|
EP2016947A1
(en)
*
|
2007-07-17 |
2009-01-21 |
Chemo Ibérica, S.A. |
Novel one step process for preparing cross-linked poly(allylamine) polymers
|
US8153617B2
(en)
*
|
2007-08-10 |
2012-04-10 |
Allaccem, Inc. |
Bridged polycyclic compound based compositions for coating oral surfaces in humans
|
US8153618B2
(en)
*
|
2007-08-10 |
2012-04-10 |
Allaccem, Inc. |
Bridged polycyclic compound based compositions for topical applications for pets
|
US8188068B2
(en)
*
|
2007-08-10 |
2012-05-29 |
Allaccem, Inc. |
Bridged polycyclic compound based compositions for coating oral surfaces in pets
|
WO2009023544A2
(en)
*
|
2007-08-10 |
2009-02-19 |
Ilypsa, Inc. |
Dosage unit anion-exchange polymer pharmaceutical compositions
|
US20090074833A1
(en)
*
|
2007-08-17 |
2009-03-19 |
Whiteford Jeffery A |
Bridged polycyclic compound based compositions for controlling bone resorption
|
TWI468167B
(zh)
|
2007-11-16 |
2015-01-11 |
威佛(國際)股份有限公司 |
藥學組成物
|
EP2217215A1
(en)
*
|
2007-12-14 |
2010-08-18 |
Genzyme Corporation |
Coated pharmaceutical compositions
|
WO2009128085A1
(en)
*
|
2008-04-15 |
2009-10-22 |
Lupin Limited |
Process for the preparation of cross-linked polyallylamine polymer
|
US20100004218A1
(en)
*
|
2008-06-20 |
2010-01-07 |
Whiteford Jeffery A |
Bridged polycyclic compound based compositions for renal therapy
|
US20100016270A1
(en)
*
|
2008-06-20 |
2010-01-21 |
Whiteford Jeffery A |
Bridged polycyclic compound based compositions for controlling cholesterol levels
|
US20110142952A1
(en)
*
|
2008-06-20 |
2011-06-16 |
Harris David J |
Pharmaceutical Compositions
|
DE102008030046A1
(de)
|
2008-06-25 |
2009-12-31 |
Ratiopharm Gmbh |
Kompaktiertes Polyallylamin-Polymer
|
US8404784B2
(en)
*
|
2008-12-03 |
2013-03-26 |
Navinta Llc |
Manufacturing process of making polymeric amine salts
|
US20100166861A1
(en)
*
|
2008-12-29 |
2010-07-01 |
Kelly Noel Lynch |
Pharmaceutical formulations of sevalamer, or salts thereof, and copovidone
|
KR20110119714A
(ko)
*
|
2009-01-22 |
2011-11-02 |
유에스브이 리미티드 |
포스페이트 결합 폴리머를 포함하는 약학적 조성물
|
AU2010261339A1
(en)
|
2009-06-16 |
2012-01-19 |
Watson Pharma Private Limited |
Processes for the preparation of sevelamer carbonate
|
US8673272B2
(en)
*
|
2009-07-27 |
2014-03-18 |
Isp Investments Inc. |
Ultraviolet-absorbing compounds
|
GB0921951D0
(en)
*
|
2009-12-16 |
2010-02-03 |
Fujifilm Mfg Europe Bv |
Curable compositions and membranes
|
JP5377265B2
(ja)
*
|
2009-12-16 |
2013-12-25 |
一般財団法人川村理化学研究所 |
ポリマー/酒石酸結晶性ナノ複合体及びその製造方法
|
US8951177B2
(en)
|
2010-01-15 |
2015-02-10 |
Graphic Packaging International, Inc. |
Flight lug for octagonal cartons
|
BR112012021444A2
(pt)
|
2010-02-24 |
2016-05-31 |
Relypsa Inc |
polímero de amina reticulado, composição farmacêutica, método de redução do colesterol ldl sérico em um indivíduo, métodos para tratar doença, de remoção de sais biliares de um indivíduo, e para melhorar o controle glicêmico em um indivíduo, e, processo para preparar o polímero de aminas.
|
JP5717422B2
(ja)
*
|
2010-11-30 |
2015-05-13 |
株式会社パイロットコーポレーション |
ゲル状組成物の製造方法
|
IT1404163B1
(it)
*
|
2011-02-01 |
2013-11-15 |
Chemi Spa |
Processo per la preparazione di poliallilamine reticolate o loro sali farmaceuticamente accettabili
|
WO2012107083A1
(en)
|
2011-02-09 |
2012-08-16 |
Synthon Bv |
Stabilized package forms of sevelamer
|
CN102796262B
(zh)
*
|
2011-05-24 |
2014-11-12 |
北大方正集团有限公司 |
一种碳酸司维拉姆的制备方法
|
EP2773329B1
(en)
|
2011-11-04 |
2016-01-13 |
Synthon BV |
Pharmaceutical compositions comprising sevelamer
|
US20130123433A1
(en)
|
2011-11-14 |
2013-05-16 |
Formosa Laboratories, Inc. |
Method for preparing poly(allylamine) hydrochloride and derivatives therefrom
|
WO2013087237A1
(en)
|
2011-12-13 |
2013-06-20 |
Synthon Bv |
Purification of sevelamer and related polyallylamines
|
EP2791183A1
(en)
|
2011-12-13 |
2014-10-22 |
Synthon BV |
Preparation of sevelamer with reduced content of allylamine
|
CN102675510B
(zh)
*
|
2012-05-28 |
2014-04-02 |
诚达药业股份有限公司 |
司维拉姆的合成工艺
|
ES2471340B1
(es)
|
2012-12-21 |
2015-08-17 |
Laboratorios Rubió, S.A. |
Composición farmacéutica oral para fármacos de elevada posología
|
WO2014159759A1
(en)
|
2013-03-13 |
2014-10-02 |
Biosphere Medical, Inc. |
Compositions and associated methods for radioisotope-binding microparticles
|
CN103446179B
(zh)
*
|
2013-05-14 |
2017-03-15 |
厦门绿洲安源投资管理有限公司 |
作为磷酸盐、脂肪酸和胆汁酸绑定螯合剂的双亲聚富勒烯树状交联聚阳离子凝胶的应用
|
RU2728778C2
(ru)
|
2013-06-05 |
2020-07-31 |
Трисида, Инк. |
Протон-связывающие полимеры для перорального введения
|
JP6903576B2
(ja)
|
2014-12-10 |
2021-07-14 |
トリシダ・インコーポレイテッドTricida, Inc. |
経口投与用プロトン結合ポリマー
|
MA41202A
(fr)
|
2014-12-18 |
2017-10-24 |
Genzyme Corp |
Copolymères polydiallymine réticulé pour le traitement du diabète de type 2
|
US10723809B2
(en)
|
2015-03-20 |
2020-07-28 |
Howard University |
Microcarriers, matrices and scaffolds for culturing mammalian cells and methods of manufacture
|
CN107428850B
(zh)
|
2015-03-20 |
2019-10-11 |
杨达志 |
多糖-聚氨共聚物及其在降低血浆中低密度脂蛋白浓度的应用
|
US10245284B2
(en)
|
2015-08-19 |
2019-04-02 |
Alpex Pharma S.A. |
Granular composition for oral administration
|
CN114853229A
(zh)
|
2016-03-08 |
2022-08-05 |
技术研究及发展基金有限公司 |
来自盐水水产养殖系统的氮物质的消毒和去除
|
MX2018013476A
(es)
|
2016-05-06 |
2019-03-28 |
Tricida Inc |
Composiciones para tratar trastornos acido-base.
|
AU2017388956A1
(en)
|
2016-12-28 |
2019-07-11 |
Fujifilm Corporation |
Emulsion of nitrogen atom-containing polymer or salt thereof, production method therefor, and production method for particles
|
CN107412166B
(zh)
*
|
2017-08-08 |
2020-03-24 |
同济大学 |
一种纳米复合吸附磷材料及其制备与应用
|
US10934380B1
(en)
|
2017-09-25 |
2021-03-02 |
Tricida, Inc. |
Crosslinked poly(allylamine) polymer pharmaceutical compositions
|
EP3698799B1
(en)
*
|
2017-10-16 |
2022-01-26 |
FUJIFILM Corporation |
Hyperphosphatemia treatment agent
|
WO2019078198A1
(ja)
|
2017-10-16 |
2019-04-25 |
富士フイルム株式会社 |
高リン血症治療剤および粒子
|
US10479865B2
(en)
|
2017-11-01 |
2019-11-19 |
Strides Shasun Limited |
Process for the preparation of sevelamer carbonate
|
CA3080651A1
(en)
|
2017-11-03 |
2019-05-09 |
Tricida, Inc. |
Compositions for and method of treating acid-base disorders
|
CN112047854B
(zh)
*
|
2020-10-20 |
2021-07-02 |
中国科学院长春应用化学研究所 |
一种n-乙烯基烷基酰胺的制备方法
|
EP4295836A1
(en)
|
2022-06-22 |
2023-12-27 |
Labomed Pharmaceutical Company S.A. |
Sachet comprising a liquid suspension of a sevelamer salt
|
WO2024084076A1
(en)
*
|
2022-10-20 |
2024-04-25 |
Universiteit Gent |
Method to prepare amidated polymers
|